SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-22-001999
Filing Date
2022-03-28
Accepted
2022-03-28 17:00:15
Documents
17
Period of Report
2022-03-28
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cannabics_8k.htm   iXBRL 8-K 27777
2 cannabics_ex0301.htm EX-3.1 2653
3 cannabics_ex9901.htm EX-99.1 6544
7 GRAPHIC img_001.jpg GRAPHIC 113307
8 GRAPHIC img_002.jpg GRAPHIC 169232
9 GRAPHIC img_003.jpg GRAPHIC 153097
  Complete submission text file 0001683168-22-001999.txt   813837

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cnbx-20220328.xsd EX-101.SCH 3036
5 XBRL LABEL FILE cnbx-20220328_lab.xml EX-101.LAB 35156
6 XBRL PRESENTATION FILE cnbx-20220328_pre.xml EX-101.PRE 23031
11 EXTRACTED XBRL INSTANCE DOCUMENT cannabics_8k_htm.xml XML 3579
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
CNBX Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

IRS No.: 203373669 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-52403 | Film No.: 22776196
SIC: 2834 Pharmaceutical Preparations